Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)

Intravenous Insulin for 24 Hours in Patients With Diabetes Mellitus Submitted to Percutaneous Coronary Intervention With Stent: Effects Upon Oxidative Stress and Inflammatory Markers

The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant defense) and inflammation (C-reactive protein (CRP) and sCD40L) in diabetic patients submitted to PCI with stent.

Inclusion Criteria:

• Patients with Diabetes Mellitus submitted to Percutaneous Coronary Intervention with Stent bare metal
• Age: 18-80 years old

Exclusion Criteria:

• Restenosis
• Drug elution stent
• Acute coronary syndrome at last 30 days
• Use anti inflammatory, antibiotic, vitamin E
• Inflammatory disease or oncologic